DTS (Dysfunctional Tear Syndrome) is a disorder of the tear film in quality and/or quantity, which is caused by a range of aetiologies and involves abnormalities in one or more components of the tear film, resulting in a constellation of signs and symptoms affecting the ocular surface
- any alteration in the quantity and/or quality of the tear film can result in DTS, a chronic condition with multiple subtypes that include dry eye disease (DED) and associated tear film disorders
   - possible symptoms of DTS are:
 - ocular discomfort
 - dryness
 - burning/stinging
 - grittiness/foreign body sensation
 - photophobia
 - blurred/fluctuating vision
 
 - overlap and frequent comorbidity of DED and other conditions affecting the quantity or quality of the tear film require careful examination of patients with DTS
 - four main subtype classifications used by the DTS Panel approach are as follows: 
- aqueous deficiency;
 - blepharitis/Meibomian Gland Dysfunction (MGD) (evaporative and nonevaporative);
 - goblet cell deficiency/ mucin deficiency;
 - exposure-related DTS
 
 - following the clinical assessment and evaluation of a patient with DTS, each patient can be classified into one or more of the disease-state subtypes (the presence of multiple subtypes within a patient is common)
 
Management options include:
- artificial tears, gels, ointments, and inserts are used to replenish the tear film
- tears can be conserved via punctal plugs, cautery, and moisture chamber eyewear
 
 - alterations in environmental conditions may benefit patients with DTS through increases in relative humidity
 - adjustments in lid hygiene, warm compresses, and massage may also be necessary for patients with blepharitis/MGD
 - anti-inflammatory and immunomodulatory agent options include:
- cyclosporine, lifitegrast, steroids, and nutritional supplements, such as omega-3 fatty acids
 
 
Reference:
- Behrens A, Doyle JJ, Stern L, et al., Dysfunctional Tear Syndrome Study Group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006; 25:900-907.
 - American Academy of Ophthalmology Cornea/External Disease Panel. Preferred practice pattern guidelines. Dry eye syndrome. San Francisco, CA: American Academy of Ophthalmology; 2013.